SPOTLIGHT -
Fort Worth, TX-Alcon Inc., the wholly owned eye-care business of Nestle .A., Vevey, Switzerland, is making preparations to conduct an initial public offering (IPO). The transaction is expected to be complete by April 1.
Aurion Biotech doses first Canadian patient in Phase 1/2 ABA-1, CLARA clinical trial of AURN001
EyePod: Modifier Gene Therapy: What is it?
Navigating ocular effects of cancer therapy: Insights from breast cancer and head-neck cancers
EyePod: Integrating cutting-edge pipeline devices for enhanced cataract surgery
ABVC BioPharma reaches global licensing deal for ophthalmology pipeline
Plastic surgery: When specialties overlap